ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
233.99
Bid
225.00
Ask
235.39
Volume
5,305
227.27 Day's Range 234.14
0.00 52 Week Range 0.00
Previous Close
233.64
Open
230.64
Last Trade
19
@
233.99
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

ANX Latest News

ADVENTRX Announces Management Promotions

SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that, effective immediately, Brian M. Culley, previously the Company's Chief Business...

ADVENTRX Appoints Icahn Representative to Board of Directors

SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that Odysseas D. Kostas, M.D. will join its Board of Directors. Dr. Kostas also will...

ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9

SAN DIEGO, Feb. 2 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the...

ADVENTRX Pharmaceuticals Announces Closing of Financing

SAN DIEGO, Jan. 7 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has completed the previously announced sale of shares of its Series E...

ADVENTRX Pharmaceuticals to Present at the OneMedForum Finance Conference on January 13

SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the...

ADVENTRX Pharmaceuticals Announces Financing

SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has signed agreements to purchase shares of its Series E convertible preferred...

ADVENTRX Pharmaceuticals Submits ANX-530 New Drug Application

SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug...

ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference

SAN DIEGO, Dec. 9 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present to...

ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514

South Korean Partner Demonstrates Bioequivalence and Similar Toxicity Profile to Taxotere SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today...

ADVENTRX Pharmaceuticals Reports Third Quarter Financial Results

SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the three and nine months ended September 30, 2009. "Our third...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
$ 4.2001
(211.12%)
120.01M
NVNINVNI Group Ltd
$ 8.26
(209.36%)
76.64M
TPICTPI Composites Inc
$ 2.45
(100.82%)
33.95M
ICGIntchains Group Ltd
$ 8.77
(88.60%)
527.61k
HSDTHelius Medical Technologies Inc
$ 0.884851
(84.34%)
120.4M
CYNCYNGN Inc
$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
$ 80.55
(8.54%)
281.23M

Discussion

View Full Feed
The Great Pumpkin The Great Pumpkin 6 minutes ago
Clueless or drunk? Irrelevant and ZERO credibility. Not worth a formal response. You’ll understand when you’re back on the pinks.

https://media4.giphy.com/media/x4kwwbqmmi6jnDC60a/giphy.gif?cid=6c09b952hys1i0s6mhwvjymhtmi5hgfcujfpji765suiu9eg&ep=v1_internal_gif_by_id&rid=giphy.gif&ct
LWLG
green maschine green maschine 9 minutes ago
A screenshot would be great.
TNXP
againstallodds againstallodds 14 minutes ago
Just a share selling scam… TOXIC!!!
PDIV
zerosnoop zerosnoop 15 minutes ago
This RECENT news is MASSIVE. CONFIRMED the PROVEN AOT is being sold GLOBALLY. The PROVEN AOT is a "GAME CHANGER" for the oil industry.

https://www.accesswire.com/952292/qs-energy-achieves-phase-4-milestone-with-southeast-asias-leading-energy-producer

https://ir.qsenergy
QSEP
4retire 4retire 15 minutes ago
So you think RGTI has shot its load? Sad
RGTI
rx7171 rx7171 16 minutes ago
And 10% penetration is also too conservative.
Even moderate AD patients will want it since no reason slowing progression not impossible and at that cost worth using.
AVXL
renaissance1 renaissance1 17 minutes ago
Any chance you could snap a screen shot of the over seas market? TIA
TNXP
SorcererDiviner18 SorcererDiviner18 18 minutes ago
That is all they are doing right now, feeding the beast.

You say that you like to use the companies own words. "Mr. Kurczodyna also stated that the next step for the Company is a valuation of our patents and a licensing strategy."

If all they do is plan to "feed the bea
BEGI
bluebird50 bluebird50 21 minutes ago
Mountain time is a good time... 😉
TNXP
giveit2me giveit2me 21 minutes ago
did Willow do that already?
GOOG
jimmy051357 jimmy051357 23 minutes ago
T - 7 days
SANP
zerosnoop zerosnoop 23 minutes ago
1. Phase 4 Milestone Achieved: We successfully completed Phase 4 testing of AOT with a leading energy producer in Southeast Asia. This achievement validated the effectiveness of our technology in improving oil transport efficiency while reducing carbon emissions.
QSEP
glens0 glens0 23 minutes ago
Webull starts trading at 2AM Mountain time.
TNXP
x993231 x993231 26 minutes ago
Lightwaves polymer is on the sending side, not the catching side.   By that I mean that it converts the data from electrons to photons it embeds the 1's and 0's into the laser as it comes off the chip to light.  A transciever does both, it converts the data from electroc to light AND back on the oth
LWLG
Kmacneill116 Kmacneill116 28 minutes ago
True $$$
SHIBUSD
NewJerichoMan NewJerichoMan 31 minutes ago
Top 5 football game tonight. Outstanding!
ASKH
FNM500K FNM500K 31 minutes ago
Can you clarify Catman loser please??
FNMA
janice shell janice shell 31 minutes ago
Study news from all sides to one topic. You guys just study news from one side and that's all.

You are projecting, like your hero.

Your Recent History

Delayed Upgrade Clock